MeVis contributes its competences in lung cancer diagnostics at the strategy conference NHS Long Term Plan 2021

MeVis Medical Solutions AG exhibits together with its distributor SynApps Solutions at the NHS Long Term Plan 2021 meeting on November 30, 2021 in London, United Kingdom.

MeVis presents its all-in-one chest CT-reading solution Veolity for lung cancer diagnostics. 

Being used worldwide, Veolity provides special support in lung cancer screening and incidental nodule management.

Currently, five NHS sites participating in the UK national screening use Veolity. Physicians benefit from AI-based CAD for better nodule detection, volumetric nodule measurements, automatic growth assessment, guideline compliant reporting (e.g. BTS, Lung-RADS, etc.) and an automated workflow which saves reading time compared to a PACS viewer.


Royal Society of Medicine
1 Wimpole St
London W1G 0AE
United Kingdom